Researchers report a complex series of other molecular, cellular, circuit and network-level changes contribute to the progression of Alzheimer's disease.
According to a new study, a new class of cancer drugs appears to affect memory in mice.
WUSTL researchers report a poor night's sleep can cause levels of amyloid beta to rise faster than the brain's waste disposal system can remove it. Researchers note frequent sleep disruptions can lead to an increased risk of developing Alzheimer's disease.
Researchers believe they may have uncovered vital clues as to how long term memories may be erased.
Researchers have developed new therapeutic molecules that appear to assist in reversing memory loss associated with depression and aging.
Researchers have identified a mechanism that occurs within the CA3 region of the hippocampus that appears to be responsible for a common type of age-related memory loss.
A newly developed antibody has shown to trigger a meaningful reduction of amyloid beta in patients with early stage Alzheimer's disease.
Researchers report a on a correlation between higher levels of NPTX2 and better brain volume and memory.
Lancaster University researchers report a drug developed to treat diabetes shows promise in reversing memory loss associated with Alzheimer's in mouse models of the disease. The drug appears to have a neuroprotective effect, enhancing brain growth factors while reducing amyloid plaques, chronic inflammation and oxidative stress. The drug also slows down the rate of neuron loss.
Cognitive enhancement drugs do not help improve cognition or function in the long term for patients with mild cognitive impairment, a new study shows.
A new study reports yoga and meditation can help reduce the cognitive and emotional problems that often precede the development of Alzheimer's disease.
A combination of neuroimaging and long term memory tests could help with the early diagnosis of Alzheimer's disease, researchers report.
